- Home
- VERU
VERU
Veru Inc.
as 01-17-2025 4:00pm EST
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.
| Founded: | 1971 | Country: | United States |
| Employees: | N/A | City: | MIAMI |
| Market Cap: | 108.8M | IPO Year: | 1990 |
| Target Price: | $4.00 | AVG Volume (30 days): | 2.2M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.28 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.36 - $1.92 | Next Earning Date: | 02-06-2025 |
| Revenue: | $16,886,419 | Revenue Growth: | 3.62% |
| Revenue Growth (this year): | -44.55% | Revenue Growth (next year): | -34.64% |
Latest Veru Inc. News
VERU Breaking Stock News: Dive into VERU Ticker-Specific Updates for Smart Investing
Simply Wall St.
5 days ago
3 US Penny Stocks With Market Caps Under $200M To Consider
Benzinga
19 days ago
Veru Sells FC2 Condom Business For $18 Million, Focuses On Biopharma Pipeline
MT Newswires
19 days ago
Veru Sells Female Condom Business to Riva Ridge Capital for $18 Million
GlobeNewswire
19 days ago
Veru Announces the Sale of the FC2 Female Condom® (Internal Condom) Business
Zacks
a month ago
Veru Inc. (VERU) Reports Q4 Loss, Tops Revenue Estimates
Simply Wall St.
a month ago
US Penny Stocks To Consider In December 2024
Simply Wall St.
a month ago
The past three years for Veru (NASDAQ:VERU) investors has not been profitable
GlobeNewswire
2 months ago
Veru to Present at the 17th International Conference of the Society on Sarcopenia, Cachexia, & Wasting Disorders
Compare VERU vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "VERU Veru Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.